companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

4P SIGNS INC

MISSISSAUGA-Canada

Company Name:
Corporate Name:
4P SIGNS INC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 3622 Greenbower Crt,MISSISSAUGA,ON,Canada 
ZIP Code:
Postal Code:
L5L 
Telephone Number: 9058280792 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
213850 
USA SIC Description:
SIGNS 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
5 & 10 AUTO REPAIR
4UR CONVENIENCE
4REFUEL
Next company profile:
4MODE GLOBAL LOGISTICS
4M TRADING COMPANY
4D CONCEPTS INC










Company News:
  • 4P-Pharma at the 3rd Paris Digital Science Innovation Day
    4P-Pharma is excited to take the stage at the 3rd Annual Paris Digital Science Innovation Day, hosted by Benchling, on 18 November at Les Salons Hoche, Paris! 🇫🇷
  • 4P Pharma, Translating Science to Medicine for Patients
    Established in 2014, 4P-Pharma is a clinical stage biotech company dedicated to addressing serious diseases with significant unmet medical needs Our goal is to bring first-in-class therapies to patients swiftly
  • 4P-Pharma welcomes Marina Vasiliou, Christian Bechon, and Alain Sainsot . . .
    “4P-Pharma is a promising French biotech company that prioritizes patients’ needs The company’s main objective is to contribute to healthcare innovation in France and Europe while maintaining its independence
  • 4P-Pharma at CPHI Frankfurt 2025
    We’re excited to announce that 4P-Pharma will be attending CPHI Frankfurt 2025 🇩🇪 Our Business Development team, Roselina Lam, Anne-Claire Gaudiez and our CMC expert, Frédéric Lallemand, will be on site to meet partners and explore new opportunities to accelerate access to treatments for patients
  • 4P-Pharma Announces Total Capital of €15 Million Successfully Secured . . .
    With this funding, 4P-pharma’s shareholders renew their confidence in the company’s drug regeneration model for untreated serious diseases They welcome the entry of Phase 2 clinical development of the two first 4P-Pharma SPVs, underlying the robust potential of the company’s business model
  • 4Moving Biotech Welcomes Luc Boblet as Chief Executive Officer - 4P Pharma
    4Moving Biotech, a subsidiary of 4P-Pharma, is pleased to announce Luc Boblet’s appointment as its new Chief Executive Officer Luc is an experienced and passionate biotech entrepreneur with two decades of experience His established track record speaks highly about his leadership and vision
  • 4Living Biotech and Sanofi sign a clinical collaboration agreement - 4P . . .
    Pascal Rigaudy, Global Head, Transplant Brands at Sanofi, mentioned that “Through its collaboration with 4P-Pharma, Sanofi is delighted to continue to advance the fight against COVID-19 and reinforce its partnership approach to promote the research and biotech sector in France, […]
  • 4Living Biotech obtains clinical trial authorizations in Europe to . . .
    4Living Biotech, a biotechnology company and subsidiary of 4P-Pharma, specializing in the treatment of respiratory infections, has received approval from the French National Agency for Medicinal Products (ANSM) and two other European agencies to initiate a Phase IIb clinical trial of LEONARDO in patients with acute respiratory failure
  • 4P-Pharma’s New R D Booster
    We’re thrilled to announce the launch of Dev4All, 4P-Pharma’s new R D booster With a strong biotech foundation and over ten years of experience, we turn innovative ideas into clinical-stage candidates
  • AI biotech Oncocross partners with 4P-Pharma, a France based biotech.
    Dr Yirang Kim, CEO of Oncocross, mentioned that “we are very excited about this collaboration with 4P-Pharma, where we can put together our AI platform technology and 4P-Pharma’s R D expertise to tackle and overcome this rare disease ”




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer